Examkin

Soru

Zorluk: ZorMonitoring and Treatment Evaluation

A 26-year-old man with a known history of ulcerative colitis is admitted to the hospital with an acute flare. He reports 10 to 12 bloody bowel movements daily and severe lower abdominal pain. His temperature is 38.4∘C38.4^\circ\text{C} (101.1∘F101.1^\circ\text{F}), blood pressure is 110/70 mm Hg110/70 \text{ mm Hg}, and heart rate is 118/min118/min. Laboratory results show a hemoglobin of 9.8 g/dL9.8 \text{ g/dL}, leukocyte count of 14,000/μL14,000/\mu\text{L}, and C-reactive protein (CRP) of 90 mg/L90 \text{ mg/L}. A diagnosis of acute severe ulcerative colitis (ASUC) is made.

Arrange the following steps in the standard evidence-based chronological sequence for the therapeutic management and monitoring of this patient.

  1. 1Rule out superimposed enteric infections (e.g., Clostridioides difficile) and initiate intravenous corticosteroids.
  2. 2Perform serial abdominal examinations and monitor vital signs continuously to detect toxic megacolon.
  3. 3Assess the objective clinical and biochemical response to initial therapy on hospital days 3 to 5.
  4. 4Initiate medical rescue therapy (e.g., infliximab) or request a surgical consultation for steroid-refractory disease.
  5. 5Transition to an oral corticosteroid taper and commence a long-term maintenance agent upon achieving clinical stability.

Cevap

The standard sequence is: rule out infections and start IV steroids, monitor closely for acute complications like toxic megacolon, formally evaluate the treatment response on days 3 to 5, escalate to medical rescue therapy if steroid-refractory, and finally de-escalate to an oral taper once clinical remission is achieved.
The standard evidence-based protocol for acute severe ulcerative colitis (ASUC) relies on a stepwise escalation and de-escalation framework centered around rigorous monitoring and treatment evaluation. It begins with ruling out superimposed infections and immediately initiating high-dose IV corticosteroids. Because ASUC carries a high short-term complication rate, intensive daily monitoring for toxic megacolon is crucial during the early stages of therapy. The hallmark of ASUC management is the mandatory treatment evaluation between hospital days 3 and 5 (using indices like the Oxford criteria, which rely on stool frequency and CRP). If the patient is determined to be steroid-refractory at this specific interval, the standard of care dictates immediate escalation to medical rescue therapy (infliximab or cyclosporine) or surgical colectomy. Finally, only after achieving clinical stability and remission, the patient is transitioned to an oral steroid taper alongside long-term maintenance therapy.

Adım Adım Çözüm

1
Exclude infection and start initial induction therapy
The patient begins intravenous corticosteroid therapy safely without exacerbating a hidden infection.
Enteric infections can trigger flares and complicate immunosuppression. IV steroids remain the first-line gold standard for ASUC induction.
2
Conduct rigorous daily clinical monitoring
The patient is closely monitored for colonic dilation, systemic toxicity, and deterioration.
Patients receiving initial high-dose steroids are at the highest risk for acute complications like toxic megacolon during the first 72 hours.
3
Evaluate treatment efficacy at the required interval
The clinical trajectory is objectively assessed on hospital days 3 to 5 using markers like CRP and daily stool frequency.
Evidence-based guidelines mandate a formal assessment at 72 to 120 hours to identify non-responders and prevent the risks of prolonged, ineffective steroid exposure.
4
Escalate to rescue therapy if indicated
Rescue medical therapy (e.g., infliximab) or surgical intervention is implemented.
Failure to meet objective response criteria by day 5 signifies steroid-refractory disease, requiring immediate escalation to alter the disease course.
5
De-escalate to outpatient maintenance therapy
The patient is transitioned to oral corticosteroids with a tapering plan and a long-term maintenance drug.
After the acute flare is resolved, management shifts to maintaining remission and minimizing the adverse effects of chronic corticosteroid use.

Anahtar Kavram

The management of acute severe ulcerative colitis follows a highly structured sequence: initial IV corticosteroids, rigorous complication monitoring, mandatory objective response evaluation between days 3 and 5, escalation to rescue therapy if refractory, and eventual transition to an oral taper for maintenance.
Bu soruyu puanla

Konular

Monitoring and Treatment Evaluation

Bu konudan daha fazla soru